Coronavirus vaccine researcher: 'People will die because of a lack of faith in the system'


The clearest way for the U.S. to emerge from the coronavirus pandemic, Stat News reports, is to achieve herd immunity through vaccination. Experts estimate that will occur once 50 to 70 percent of the population is protected. But, as Kawsar Talaat, a vaccine researcher at Johns Hopkins University points out, "the most effective vaccine in the world is useless if no one will accept it."
There's a lot of skepticism about a coronavirus vaccine across the political spectrum in the U.S. A new Axios poll released Tuesday showed that only 43 percent of Democrats and 33 percent of Republicans would take a first-generation vaccine as soon as it's available, and the numbers have trended downward rapidly over the last few months.
The expectation is that there will be more than one vaccine rolling out over time, so it's possible those numbers would go back up as safety and efficacy become more clear, but there's certainly a disconnect between the public and the government and scientific community on the issue. "I think people will die because of a lack of faith in the system," Talaat said, arguing that the Centers for Disease Control and Prevention have wavered on testing guidelines, and the Food and Drug Administration has been undermined by the optics of political interference from the Trump Administration. Stat notes that others want vaccine makers to be more transparent about the process.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Either way, Talaat said, "you can't talk your way into trust. You need to demonstrate that you're trustworthy, and that the process is trustworthy." Read more about how the pandemic may play out over the course of the next year at Stat News.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
5 unusually elusive cartoons about the Epstein files
Cartoons Artists take on Pam Bondi's vanishing desk, the Mar-a-Lago bathrooms, and more
-
Lemon and courgette carbonara recipe
The Week Recommends Zingy and fresh, this pasta is a summer treat
-
Corbynism returns: a new party on the Left
Talking Point Jeremy Corbyn and Zarah Sultana's breakaway progressive party has already got off to a shaky start
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths